Identification of complement C3 as an autoantigen in inflammatory bowel disease

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 4, 2010, Pages 429-436

  Lundgren, Brita Ardesjö ^a   Rorsman, Fredrik ^a   Portela Gomes, Guida M ^b   Grimelius, Lars ^b   Ekdahl, Kristina Nilsson ^c   Nilsson, Bo ^c   Ekwall, Olov ^a,d  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Genetics and Pathology ^*  (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Autoantibody; Complement C3; Crohn's disease; Goblet cell; Inflammatory bowel disease; Mucin; Primary sclerosing cholangitis; Ulcerative colitis

Indexed keywords

AUTOANTIGEN; COMPLEMENT COMPONENT C3;

APPENDIX; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA LIBRARY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCLEROSING CHOLANGITIS; WESTERN BLOTTING;

ANTIBODY SPECIFICITY; APPENDIX; AUTOANTIGENS; BIOLOGICAL MARKERS; CHOLANGITIS, SCLEROSING; COMPLEMENT C3; GOBLET CELLS; HT29 CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 77949437614     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32833283b1     Document Type: Article

References (33)

1. Farmer R, Michener W. Association of inflammatory bowel disease in families. Front Gastrointest Res 1986; 11:17-26.
2. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sørensen TI, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991; 324:84-88.
3. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008; 8:458-466.
4. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117:514-521.
5. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115:182-205.
6. Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F. Regulatory T cells and intestinal homeostasis. Immunol Rev 2005; 204:184-194.
7. Makita S, Kanai T, Oshima S, Uraushihara K, Totsuka T, Sawada T, et al. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 2004; 173:3119-3130
8. Sakamaki S, Takayanagi N, Yoshizaki N, Hayashi S, Takayama T, Kato J, et al. Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells. Gut 2000; 47:236-241.
9. Harrison WJ. Autoantibodies against intestinal and gastric mucous cells in ulcerative colitis. Lancet 1965; 1:1346-1350.
10. Hibi T, Aiso S, Ishikawa M, Watanabe M, Yoshida T, Kobayashi K, et al. Circulating antibodies to the surface antigens on colon epithelial cells in ulcerative colitis. Clin Exp Immunol 1983; 54:163-168.
11. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86:202-210.
12. Folwaczny C, Noehl N, Tschöp K, Endres SP, HeldweinW, Loeschke K, et al. Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterology 1997; 113:101-106.
13. Lawrance IC, Hall A, Leong R, Pearce C, Murray K. A comparative study of goblet cell and pancreatic exocine autoantibodies combined with ASCA and pANCA in Chinese and Caucasian patients with IBD. Inflamm Bowel Dis 2005; 11:890-897.
14. Hall R, Stanbury JB. Familial studies of autoimmune thyroiditis. Clin Exp Immunol 1967; 2 (Suppl):719-725.
15. Yu L, Cuthbertson DD, Maclaren N, Jackson R, Palmer JP, Orban T, et al. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1. Diabetes 2001; 50:1735-1740.
16. Ardesjö B, Portela-Gomes GM, Rorsman F, Rorsman F, Gerdin E, Lööf L, et al. Immunoreactivity against goblet cells in patients with inflammatory bowel disease. Inflamm Bowel Dis 2008; 14:652-661.
17. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 2008; 105:15064-15069.
18. Wong WM, Poulsom R,Wright NA. Trefoil peptides. Gut 1999; 44:890-895.
19. Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 2003; 4:721-732.
20. Podolsky DK, Isselbacher KJ. Composition of human colonic mucin. Selective alteration in inflammatory bowel disease. J Clin Invest 1983; 72:142-153.
21. Jacobs LR, Huber PW. Regional distribution and alterations of lectin binding to colorectal mucin in mucosal biopsies from controls and subjects with inflammatory bowel diseases. J Clin Invest 1985; 75:112-118.
22. Ardesjö B, Hansson CM, Bruder CEG, Rorsman F, Betterle C, Dumanski J, et al. Autoantibodies against glutathione S-transferase theta-1 in patients with autoimmune disease. Journal of Autoimmunity 2008; 30:273-282.
23. Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 1990; 50:6334-6343.
24. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-580.
25. Rorsman F, Husebye ES, Winqvist O, Bjö rk E, Karlsson FA, Kämpe O. Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen. Proc Natl Acad Sci U S A 1995; 92:8626-8629.
26. Nilsson B, Ekdahl KN, Svarvare M, Bjelle A, Nilsson UR. Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function. Clin Exp Immunol 1990; 82:262-267.
27. Nilsson UR, Storm KE, Elwing H, Nilsson B. Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface. Mol Immunol 1993; 30:211-219.
28. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest 1993; 92:2377-2385.
29. Sahu A, Lambris JD. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 2001; 180:35-48.
30. Bene L, Fü st G, Fekete B, Kovács A, Horvá th L, Prohá szka Z, et al. High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitis. Dig Dis Sci 2003; 48:1186-1192.
31. Boberg KM, Lundin KE, Schrumpf E. Etiology and pathogenesis in primary sclerosing cholangitis. Scand J Gastroenterol Suppl 1994; 204:47-58.
32. Garred P, Lyon H, Christoffersen P, Mollnes TE, Tranum-Jensen J. Deposition of C3, the terminal complement complex and vitronectin in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 1993; 13:305-310.
33. Norsworthy P, Davies KA. Complement components and their autoantibodies. Mol Biotechnol 2003; 23:259-270.